Global Life Sciences
Overview
Featured News & Insights
0015
Contacts
Services
Advising on the full scope of regulatory, compliance and enforcement, litigation and transactional matters, we can offer you a holistic legal approach that will smooth your path as you navigate industry changes, technological advances, market demands and policy hurdles.
Regions
From high-profile transactions to regulatory issues and complex litigation, we collaborate across borders and disciplines to help our clients in more than 70 countries face challenges and embrace opportunities.

All Professionals
sort


Capabilities
- Antitrust and Competition
- Capital Markets
- Commercial Litigation and Disputes
- Emerging Companies and Venture Capital
- Environmental, Health, and Safety
- Food, Drug and Medical Device
- Global Arbitration, Trade and Advocacy
- Government Strategies
- Healthcare
- IP Litigation
- M&A
- Privacy and Cybersecurity
- Private Equity
- Product Liability and Mass Torts
- Technology
- Technology and Life Sciences Transactions
Related Resources
Areas of Focus
Related Blogs
News & Insights
GMP 2026: Regulatory Reliance, AI, and the Future of Pharmaceutical ManufacturingWednesday, December 2, 2026Sidley Recognized in Legal 500 Greater China 2027November 19, 2026Sidley Shortlisted at the Legal 500 China Awards 2026November 19, 2026Major Medicare Part B Payment Changes Finalized for 2027November 19, 2026
Events
Accolades
Accolades
Global Life Sciences Update
Major Medicare Part B Payment Changes Finalized for 2027November 19, 2026CMS Announces Plans to Expand Voluntary Cell and Gene Therapy Access Model Beyond Sickle Cell DiseaseNovember 12, 2026U.S. Treasury Proposes Sweeping Limits on U.S. Investments in “Countries of Concern”: Biotechnology, Super Intelligence, and MoreOctober 28, 2026Treasury Proposes to Prohibit U.S. Investment in Chinese Biotech: What It Means for China Licensing DealsOctober 28, 2026
Global Life Sciences Update
Global Life Sciences Update
Global Arbitration, Trade and Advocacy Update
Global Life Sciences Update
A Breakout Year for CVRs: 2025 and First-Half 2026 Trends in Life Sciences Public M&AOctober 6, 2026Texas Medicaid Fraud Decision Leaves 2 Open QuestionsOctober 1, 2026New York Ethics Opinion Warns Lawyers on Qui Tam DeceptionSeptember 2, 2026Recent ESG Developments in EuropeAugust 2026
Publications
Law360
Law360
Sidley Life Sciences Briefing
Sidley Continues Strategic Growth of Global Life Sciences Practice With Addition of Corporate Lawyers Deepa Rich and Sam ZuckerNovember 18, 2026Sidley Represents Sino Biopharmaceutical in its US$7 Billion Licensing Agreement With Boehringer IngelheimNovember 9, 2026Sidley Represents Laza Medical in Its US$160 Million Series B Financing RoundNovember 4, 2026Introducing SidleyCatalyst: Built to Accelerate GrowthOctober 28, 2026
Press Releases
Announcements
Announcements
Announcements
Sidley Recognized in Legal 500 Greater China 2027November 19, 2026Sidley Shortlisted at the Legal 500 China Awards 2026November 19, 2026Sidley Deals Honored at the IFLR Asia-Pacific Awards 2026November 17, 2026Three Sidley Partners Recognized as 2026 “Consumer Goods Business Visionaries”October 20, 2026
Accolades
Accolades
Accolades
Accolades
What Does It Take to Build a Business Around a Single Patient? Emerging “N-of-1” Models and the Regulatory Road AheadNovember 13, 2026Treasury Proposes to Prohibit U.S. Investment in Chinese Biotech: What It Means for China Licensing DealsNovember 13, 2026The Growing PFAS Focus in Europe and the UK – Strategies for Life Sciences CompaniesOctober 27, 2026A More Competitive MedTech Landscape in the EU? What the MDR/IVDR Revision Could Mean for MedTech Manufacturers and InvestorsOctober 16, 2026
GoodLifeSci
GoodLifeSci
GoodLifeSci
GoodLifeSci
Renewed Market Optimism @ JPM 2026January 12, 2026What's Ahead for Life Sciences Dealmaking @ JPM 2026January 12, 2026Top 10 FDA Areas We Are Watching @ JPM 2026January 12, 2026Regulatory Considerations for the Next Wave of Development-Stage Transactions @ JPM 2026January 12, 2026
Videos
Videos
Videos
Videos




































